KEI & UNU-MERIT Maastricht Workshop on Medical Innovation Prizes

Written by Administrator
Friday, 18 January 2008

Medical innovation prizes as a mechanism to promote innovation and access

Date: January 28-29, 2008

Location: UNU-MERIT in Maastricht, The Netherlands 

Monday morning: Aula, Maastricht University, Faculty of Economics, Tongersestraat 53
Monday afternoon & Tuesday: Aula, Maastricht University, Minderbroedersberg 4-6

The workshop is open to the public and there is no fee to attend. Register at http://ccg.merit.unu.edu/prizefund/  

For more information, please contact Karsten Gerloff <gerloff at merit.unu.edu> or Malini Aisola <malini.aisola at keionline.org> 

Monday, Jan 28

09:00  Welcome
  
    Konrad Osterwalder, Rector, United Nations University
    James Love, Knowledge Ecology International (KEI)

09:15  Panel 1  Overview, prizes to stimulate innovation

    Chair:  Kalipso Chalkidou, Johns Hopkins School of Public Health on secondment from UK NICE

    William Fisher, Harvard Law School: Prizes for medical innovation
    Steve Merrill, US National Academy of Science: Innovation prizes in other fields

10:45  Break
 
11:00  Panel 2  Prizes, the U.S. and European Context

    Chair:  Suerie Moon, Harvard, KSG

    Dwayne Spradlin, CEO, InnoCentive: Prizes for Research tools and Basic Medical Research
    Nicole Szlezak, Board of Directors, Prize4Life
    David Reynolds, US Senator Sanders Office, S.2210: The Medical Innovation Prize Act
    Joan Rovira, Autonomous University of Barcelona, Spain

13:00  Venue change & Lunch
 
14:30  Panel 3  Prizes for developing countries

    Chair: Thiru Balasubramaniam, KEI

    Pierre Chirac, Medecins sans Frontieres: Prize for TB low-cost point of care rapid diagnostic test
    Aidan Hollis, University of Calgary: A voluntary prize mechanism

15:30  Break

15:45  Panel 4  Issues in Prize Design

    Chair: Ahmed Abdel Latif, ICTSD

    John Erickson, CEO Sequoia Pharmaceuticals: A system of prizes that rewards product development in stages
    James Love, KEI: Prizes and follow-on innovation

16:45  Panel 5  Views of Developing Countries

    Chair: Spring Gombe, KEI

    Dilip Shah, Secretary General, Indian Pharmaceutical Alliance
    Ahmed Abdel Latif, International Centre for Trade and Sustainable Development (ICTSD)
    A.E. Ogwell, Kenya Ministry of Health

18:00  End of the first day

19:00  Speakers' dinner

Tuesday, Jan 29
  
09:00  Panel 6  – Economists on prizes

    Chair: Rishab Ghosh, UNU-MERIT

    Ove Grandstrand, Chalmers University of Technology, Sweden
    Lee Davis, Copenhagen Business School
    Bart Verspagen, Eindhoven University of Technology
        

10:30  Break
 
10:45  Panel 7   Sustainable financing for prizes

    Chair: Charles Clift, DFID

    Michelle Childs, KEI: A prize mechanism for UNITAID/Global Fund
    Peter Brown, SecurePharma: possible role of the International Finance Facility (IFF) in providing credible and sustainable sources of funding for innovation prizes for neglected diseases
    Nicoletta Dentico, Drugs for Neglected Diseases Initiative (DNDi):  Transaction based funding mechanisms for public goods
    James Love, KEI: Creating Fixed Amount Prize Funds that will be divided among qualifying projects, with total funding a fraction of GDP or health care budgets
    Respondent: Luc Soete, UNU-MERIT

12:30  Lunch

14:00  Panel 8      The management of prizes

    Chair: Oliver Moldenhauer, MSF

     Amy Kapczynski, University of California, Berkeley
     Ron Marchant, former Chief Executive of the UK Intellectual Property Office
     Kalipso Chalkidou, Johns Hopkins School of Public Health on secondment from UK NICE: Valuing prizes and making reimbursement decisions: how different?

16:00  Break
 
16:15  Panel 9    Conclusions and Next Steps

    Chair: Amy Kapczynski, University of California, Berkeley

    A.E. Ogwell, Kenya Ministry of Health
    Rishab Ghosh, UNU-MERIT
    James Love, KEI

17:30  End of the workshop